GENEREACH BIOTECHNOLOGY CORPGENEREACH BIOTECHNOLOGY CORPGENEREACH BIOTECHNOLOGY CORP

GENEREACH BIOTECHNOLOGY CORP

No trades
See on Supercharts

4171 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

GeneReach Biotechnology Corp. develops, manufactures and markets products for applied nucleic acid detection technology. The company mainly involves in the manufacture of animal drugs & chemical products, medical equipment, general instrument and provides biotechnology services. It offers complete disease management solution for the aquaculture farming industry, such as polymerase chain reaction detection kit, robust mobile polymerase chain reaction detection system; in-clinic nucleic acid detection system for companion animal health management and total deoxyribonucleic acid extraction kit used for nucleic acid automatic extraction system. GeneReach Biotechnology was founded by Cheng Chung Liu on November 12, 2004 and is headquartered in Taichung, Taiwan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
4171 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company